Please Wait
Applying Filters...
menu
    • menu
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.

    Virtual Booth

    Contact Supplier

    Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    Menu

    Tesofensine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 195875-84-4, Ns-2330, Tesofensine [inn], Ns 2330, Blh9ukx9v1, (1r,2r,3s,5s)-3-(3,4-dichlorophenyl)-2-(ethoxymethyl)-8-methyl-8-azabicyclo[3.2.1]octane
    Molecular Formula
    C17H23Cl2NO
    Molecular Weight
    328.3  g/mol
    InChI Key
    VCVWXKKWDOJNIT-ZOMKSWQUSA-N
    FDA UNII
    BLH9UKX9V1
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (1R,2R,3S,5S)-3-(3,4-dichlorophenyl)-2-(ethoxymethyl)-8-methyl-8-azabicyclo[3.2.1]octane
    2.1.2 InChI
    InChI=1S/C17H23Cl2NO/c1-3-21-10-14-13(9-12-5-7-17(14)20(12)2)11-4-6-15(18)16(19)8-11/h4,6,8,12-14,17H,3,5,7,9-10H2,1-2H3/t12-,13+,14+,17+/m0/s1
    2.1.3 InChI Key
    VCVWXKKWDOJNIT-ZOMKSWQUSA-N
    2.1.4 Canonical SMILES
    CCOCC1C2CCC(N2C)CC1C3=CC(=C(C=C3)Cl)Cl
    2.1.5 Isomeric SMILES
    CCOC[C@H]1[C@H]2CC[C@H](N2C)C[C@@H]1C3=CC(=C(C=C3)Cl)Cl
    2.2 Other Identifiers
    2.2.1 UNII
    BLH9UKX9V1
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. (1r-(2-endo,3-exo))-3-(3,4-dichlorophenyl)-2-(ethoxymethyl)-8-methyl-8-azabicyclo(3,2,1)octane-2-hydroxy-1,2,3-propanetricarboxylate

    2.3.2 Depositor-Supplied Synonyms

    1. 195875-84-4

    2. Ns-2330

    3. Tesofensine [inn]

    4. Ns 2330

    5. Blh9ukx9v1

    6. (1r,2r,3s,5s)-3-(3,4-dichlorophenyl)-2-(ethoxymethyl)-8-methyl-8-azabicyclo[3.2.1]octane

    7. (1r,2r,3s,5s)-3-(3,4-dichlorophenyl)-2-(ethoxymethyl)-8-methyl-8-azabicyclo(3.2.1)octane

    8. Unii-blh9ukx9v1

    9. Tesofensine [mi]

    10. Tesofensine [mart.]

    11. Schembl37509

    12. Tesofensine [who-dd]

    13. Chembl3989690

    14. Dtxsid70905114

    15. Zinc3953158

    16. Ns2330

    17. Db06156

    18. Hy-14472

    19. Cs-0003378

    20. J-012675

    21. Q7705544

    22. (1r,2r,3s)-2-ethoxymethyl-3-(3,4-dichlorophenyl)tropane

    23. (1r, 2r, 3s)-2-ethoxymethyl-3-(3,4-dichlorophenyl)tropane

    24. (1r-(2-endo,3-exo))-3-(3,4-dichlorophenyl)-2-(ethoxymethyl)-8-methyl-8-azabicyclo(3,2,1)octane-2-hydroxy-1,2,3-propanetricarboxylate

    25. 8-azabicyclo(3.2.1)octane, 3-(3,4-dichlorophenyl)-2-(ethoxymethyl)-8-methyl-, (1r-(2-endo,3-exo))-

    2.4 Create Date
    2006-10-26
    3 Chemical and Physical Properties
    Molecular Weight 328.3 g/mol
    Molecular Formula C17H23Cl2NO
    XLogP34.5
    Hydrogen Bond Donor Count0
    Hydrogen Bond Acceptor Count2
    Rotatable Bond Count4
    Exact Mass327.1156697 g/mol
    Monoisotopic Mass327.1156697 g/mol
    Topological Polar Surface Area12.5 Ų
    Heavy Atom Count21
    Formal Charge0
    Complexity354
    Isotope Atom Count0
    Defined Atom Stereocenter Count4
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    Investigated for use/treatment in alzheimer's disease, parkinson's disease, and obesity.

    5 Pharmacology and Biochemistry
    5.1 Mechanism of Action

    Tesofensine is a Serotonin-norepinephrine-dopamine-reuptake-inhibitor (SNDRI). SNDRIs are a class of psychoactive antidepressants. They act upon neurotransmitters in the brain, namely, serotonin, norepinephrine and dopamine. These three biogenic monoamines are associated with depression and increasing the availability in the brain is one method used to treat the condition.